Cargando…
Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
BACKGROUND: Patients with irritable bowel syndrome (IBS) seen by a gastroenterologist often utilize medications that may alter intestinal homeostasis. The question arises whether exposure to these drugs is associated with the development of IBS symptoms. Aim of this study was therefore to assess the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482574/ https://www.ncbi.nlm.nih.gov/pubmed/22950677 http://dx.doi.org/10.1186/1471-230X-12-121 |
_version_ | 1782247882559062016 |
---|---|
author | Keszthelyi, Daniel Dackus, Gwen H Masclee, Gwen M Kruimel, Joanna W Masclee, Ad AM |
author_facet | Keszthelyi, Daniel Dackus, Gwen H Masclee, Gwen M Kruimel, Joanna W Masclee, Ad AM |
author_sort | Keszthelyi, Daniel |
collection | PubMed |
description | BACKGROUND: Patients with irritable bowel syndrome (IBS) seen by a gastroenterologist often utilize medications that may alter intestinal homeostasis. The question arises whether exposure to these drugs is associated with the development of IBS symptoms. Aim of this study was therefore to assess the use of PPIs and NSAIDs in patients with IBS versus controls. METHODS: Cases of IBS from the last 5 years were reviewed. All patients having had at least one prescription for a particular drug (PPIs, NSAIDs, SSRIs, diuretics, ACE inhibitors) in the 6 months prior to the time of initial symptom onset were considered exposed. The control group consisted of individuals randomly selected from the general population. RESULTS: 287 cases of IBS were retrieved for analysis together with 287 age and sex-matched controls. Exposure to PPIs and NSAIDs was significantly higher in IBS patients, whereas no association between ACE inhibitor use and IBS was found. PPIs were not significantly associated when excluding patients with gastrointestinal reflux disease or functional dyspepsia. Exposure to SSRIs was also positively associated with IBS, but only when patients with psychiatric comorbidity were included in the analyses. CONCLUSIONS: Medications that may alter intestinal homeostasis such as NSAIDs and PPIs were more frequently used in IBS patients compared to controls. This association might be relevant for everyday clinical practice, but it is remains to be elucidated whether this association is of etiological nature. |
format | Online Article Text |
id | pubmed-3482574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34825742012-10-29 Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study Keszthelyi, Daniel Dackus, Gwen H Masclee, Gwen M Kruimel, Joanna W Masclee, Ad AM BMC Gastroenterol Research Article BACKGROUND: Patients with irritable bowel syndrome (IBS) seen by a gastroenterologist often utilize medications that may alter intestinal homeostasis. The question arises whether exposure to these drugs is associated with the development of IBS symptoms. Aim of this study was therefore to assess the use of PPIs and NSAIDs in patients with IBS versus controls. METHODS: Cases of IBS from the last 5 years were reviewed. All patients having had at least one prescription for a particular drug (PPIs, NSAIDs, SSRIs, diuretics, ACE inhibitors) in the 6 months prior to the time of initial symptom onset were considered exposed. The control group consisted of individuals randomly selected from the general population. RESULTS: 287 cases of IBS were retrieved for analysis together with 287 age and sex-matched controls. Exposure to PPIs and NSAIDs was significantly higher in IBS patients, whereas no association between ACE inhibitor use and IBS was found. PPIs were not significantly associated when excluding patients with gastrointestinal reflux disease or functional dyspepsia. Exposure to SSRIs was also positively associated with IBS, but only when patients with psychiatric comorbidity were included in the analyses. CONCLUSIONS: Medications that may alter intestinal homeostasis such as NSAIDs and PPIs were more frequently used in IBS patients compared to controls. This association might be relevant for everyday clinical practice, but it is remains to be elucidated whether this association is of etiological nature. BioMed Central 2012-09-05 /pmc/articles/PMC3482574/ /pubmed/22950677 http://dx.doi.org/10.1186/1471-230X-12-121 Text en Copyright ©2012 Keszthelyi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Keszthelyi, Daniel Dackus, Gwen H Masclee, Gwen M Kruimel, Joanna W Masclee, Ad AM Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study |
title | Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study |
title_full | Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study |
title_fullStr | Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study |
title_full_unstemmed | Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study |
title_short | Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study |
title_sort | increased proton pump inhibitor and nsaid exposure in irritable bowel syndrome: results from a case-control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482574/ https://www.ncbi.nlm.nih.gov/pubmed/22950677 http://dx.doi.org/10.1186/1471-230X-12-121 |
work_keys_str_mv | AT keszthelyidaniel increasedprotonpumpinhibitorandnsaidexposureinirritablebowelsyndromeresultsfromacasecontrolstudy AT dackusgwenh increasedprotonpumpinhibitorandnsaidexposureinirritablebowelsyndromeresultsfromacasecontrolstudy AT mascleegwenm increasedprotonpumpinhibitorandnsaidexposureinirritablebowelsyndromeresultsfromacasecontrolstudy AT kruimeljoannaw increasedprotonpumpinhibitorandnsaidexposureinirritablebowelsyndromeresultsfromacasecontrolstudy AT mascleeadam increasedprotonpumpinhibitorandnsaidexposureinirritablebowelsyndromeresultsfromacasecontrolstudy |